> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Hearing on Regulatory Science for Generic Drugs
- URL: https://www.fdaweb.com/public-hearing-on-regulatory-science-for-generic-drugs/
- Published: 2016-03-09T12:00:00.000Z
- Updated: 2026-09-15T02:42:05.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135029

*Federal Register* Notice: FDA will hold a public hearing 5/20 that will provide an overview of the current status of regulatory science initiatives for generic drugs and an opportunity for public input on research priorities in this area. FDA is seeking this input from a variety of stakeholders — industry, academia, patient advocates, professional societies, and other interested parties. The agency will take the information it obtains from the public hearing into account in developing the fiscal year 2017 Regulatory Science Plan. The hearing will be held from 9 a.m. to 5 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-03-09/pdf/2016-05221.pdf?ref=fdaweb.com).